|
E-75 vaccines
Below is the E-75 vaccine editoral from Oct. 2005, describing the progress of the her2 vaccines. It appears that the overall DFS was improved by 60% on the vaccinated group as opposed to the control group. Obviously, a success in terms of adjuvant treatment for early stage her2 neu breast cancer treatment. This is phas II of the vaccine trails.
__________________
Robin
2002- dx her2 positive DCIS/bc TX Mast, herceptin chemo
Last edited by RobinP; 12-06-2005 at 06:22 PM..
|